Algorithm for Sequencing Glucose-Lowering Therapies in Type 2 Diabetes

Mohammed Al-Sofiani, M.B.B.S, Anda Gonciulea, M.D., Rita Rastogi Kalyani, M.D., M.H.S.

Algorithm for Sequencing Glucose-Lowering Therapies in Type 2 Diabetes is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please log in or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Monkeypox

Coronavirus COVID-19 (SARS-CoV-2)

Suicide Risk in the COVID-19 Pandemic

Moderna COVID-19 Vaccine

BNT162b2 COVID-19 Vaccine (BioNTech/Pfizer)

Managing Stress and Coping with COVID-19

Johnson & Johnson COVID-19 Vaccine

-- The first section of this topic is shown below --

INTRODUCTION

Glycemic management in type 2 diabetes is complex and evolving, with many new therapies for type 2 diabetes having been introduced over the past few years.
More recent guidelines emphasize a patient-centered approach and also take into consideration patient factors when choosing therapies and appropriate glycemic goals (i.e. patient involvement and expected efforts; comorbidities, especially established vascular complications; disease duration; life expectancy).
Other factors to consider when choosing therapies for type 2 diabetes might include: efficacy, cost, available resources and support system, fasting versus postprandial hyperglycemia, risk of hypoglycemia, weight changes, drug side effects, route of administration, and drug’s mechanism of action.

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INTRODUCTION

Glycemic management in type 2 diabetes is complex and evolving, with many new therapies for type 2 diabetes having been introduced over the past few years.
More recent guidelines emphasize a patient-centered approach and also take into consideration patient factors when choosing therapies and appropriate glycemic goals (i.e. patient involvement and expected efforts; comorbidities, especially established vascular complications; disease duration; life expectancy).
Other factors to consider when choosing therapies for type 2 diabetes might include: efficacy, cost, available resources and support system, fasting versus postprandial hyperglycemia, risk of hypoglycemia, weight changes, drug side effects, route of administration, and drug’s mechanism of action.

There's more to see -- the rest of this entry is available only to subscribers.